Trace the evidence
The document behind
the discussion.
A regulatory request, a product label and a clinical guideline do different work. Check their dates and read the source beside the claim.
CoreAge Rx: Injectable TRTChecked 2026-09-27
Provider product and service page
Source checked 2026-09-27. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
- CoreAge Rx testosterone injection review: establish the diagnosis and the care plan
- Testosterone care documents compared: diagnosis, medicine identity and continuing responsibility
- Testosterone blood pressure labeling: FDA dates and product records
- Testosterone monitoring record: questions, results and responsibility
Endocrine Society: Statement on Testosterone Replacement Therapy, July 16, 2026Checked 2026-09-27
Current professional society statement
Source checked 2026-09-27. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
- CoreAge Rx testosterone injection review: establish the diagnosis and the care plan
- Testosterone care documents compared: diagnosis, medicine identity and continuing responsibility
- TRT Nation testosterone document review: assessment and continuing responsibility
- Defy Medical testosterone review: assessment, costs and follow-up
- Low testosterone: why symptoms, repeat testing and cause belong together
- Testosterone blood pressure labeling: FDA dates and product records
- Testosterone monitoring record: questions, results and responsibility
FDA: Understanding the Risks of Compounded DrugsChecked 2026-09-27
Regulatory explanation
Source checked 2026-09-27. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
- CoreAge Rx testosterone injection review: establish the diagnosis and the care plan
- Testosterone care documents compared: diagnosis, medicine identity and continuing responsibility
- TRT Nation testosterone document review: assessment and continuing responsibility
- Testosterone blood pressure labeling: FDA dates and product records
Pfizer: Depo-Testosterone prescribing information, revised September 2025Checked 2026-09-27
Exact manufacturer prescribing information
Source checked 2026-09-27. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
- CoreAge Rx testosterone injection review: establish the diagnosis and the care plan
- Testosterone care documents compared: diagnosis, medicine identity and continuing responsibility
- TRT Nation testosterone document review: assessment and continuing responsibility
- Defy Medical testosterone review: assessment, costs and follow-up
- Testosterone blood pressure labeling: FDA dates and product records
Endocrine Society: Testosterone Therapy in Men With Hypogonadism guideline, 2018Checked 2026-09-27
Clinical practice guideline
Source checked 2026-09-27. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
- CoreAge Rx testosterone injection review: establish the diagnosis and the care plan
- Testosterone care documents compared: diagnosis, medicine identity and continuing responsibility
- TRT Nation testosterone document review: assessment and continuing responsibility
- Defy Medical testosterone review: assessment, costs and follow-up
- Low testosterone: why symptoms, repeat testing and cause belong together
- Bring the fertility question before a testosterone prescription
- Testosterone monitoring record: questions, results and responsibility
FDA: February 28, 2025 class-wide testosterone labeling changesChecked 2026-09-27
Dated regulatory action
Source checked 2026-09-27. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
- CoreAge Rx testosterone injection review: establish the diagnosis and the care plan
- Testosterone care documents compared: diagnosis, medicine identity and continuing responsibility
- TRT Nation testosterone document review: assessment and continuing responsibility
- Defy Medical testosterone review: assessment, costs and follow-up
- Testosterone blood pressure labeling: FDA dates and product records
FDA: Testosterone Information, June 2026 labeling updateChecked 2026-09-27
Current regulatory information
Source checked 2026-09-27. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
- CoreAge Rx testosterone injection review: establish the diagnosis and the care plan
- Testosterone care documents compared: diagnosis, medicine identity and continuing responsibility
- TRT Nation testosterone document review: assessment and continuing responsibility
- Defy Medical testosterone review: assessment, costs and follow-up
- Low testosterone: why symptoms, repeat testing and cause belong together
- Testosterone blood pressure labeling: FDA dates and product records
TRT Nation: 2026 Frequently Asked QuestionsChecked 2026-09-27
Provider price, access and service terms
Source checked 2026-09-27. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
TRT Nation: Cost and Process, updated April 2026Checked 2026-09-27
Provider price and process explanation
Source checked 2026-09-27. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Defy Medical: Testosterone Replacement Therapy OnlineChecked 2026-09-27
Provider service page
Source checked 2026-09-27. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Defy Medical: How much does TRT cost?Checked 2026-09-27
Provider illustrative cost estimate
Source checked 2026-09-27. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Defy Medical: What is the cost of TRT?Checked 2026-09-27
Provider cost and marketing explanation
Source checked 2026-09-27. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
American Urological Association: Evaluation and Management of Testosterone Deficiency, 2024Checked 2026-09-27
Clinical practice guideline
Source checked 2026-09-27. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
DailyMed: Depo-Testosterone cypionate injection, updated August 21, 2026Checked 2026-09-27
Exact prescription product labeling
Source checked 2026-09-27. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
Lincoff et al.: Cardiovascular Safety of Testosterone-Replacement Therapy, 2023Checked 2026-09-27
Primary randomized trial abstract
Source checked 2026-09-27. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
ASRM ReproductiveFacts: Testosterone use and male infertility, revised 2021Checked 2026-09-27
Reproductive medicine society patient information
Source checked 2026-09-27. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
ASRM ReproductiveFacts: Male fertility evaluation, revised 2023Checked 2026-09-27
Reproductive medicine society patient information
Source checked 2026-09-27. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
NYU Langone: Department of Urology DivisionsChecked 2026-09-29
Official academic clinical-service description; public service record, not a personal diagnosis or outcome
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
NYU Langone: Hossein Sadeghi-Nejad, MDChecked 2026-09-29
Official clinical practitioner profile; public service record, not a personal diagnosis or outcome
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
NewYork-Presbyterian: Iris Cantor Men’s Health Center clinical servicesChecked 2026-09-29
Official multispecialty center service page; public service record, not a personal diagnosis or outcome
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Hartford HealthCare: Tallwood hypogonadismChecked 2026-09-29
Official condition page within named clinical institute; public service record, not a personal diagnosis or outcome
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Hartford HealthCare: Tallwood Men’s Health endocrinologyChecked 2026-09-29
Official named clinical service; public service record, not a personal diagnosis or outcome
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Henry Ford Health: Men’s Health Center low testosteroneChecked 2026-09-29
Official named urology assessment/treatment service; public service record, not a personal diagnosis or outcome
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Corewell Health: EndocrinologyChecked 2026-09-29
Official endocrine assessment service; public service record, not a personal diagnosis or outcome
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Geisinger: Vishaal Gupta, MDChecked 2026-09-29
Official adult endocrinology clinical profile; public service record, not a personal diagnosis or outcome
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
UCSF: James F. Smith clinical profileChecked 2026-09-29
Official urology faculty clinical-care profile; public service record, not a personal diagnosis or outcome
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
UCSF Urology: Hypogonadism (Low Testosterone)Checked 2026-09-29
Official departmental patient education paired with service profile; public service record, not a personal diagnosis or outcome
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Yale Medicine: UrologyChecked 2026-09-29
Official system clinical department; public service record, not a personal diagnosis or outcome
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Yale Medicine: Stanton Honig, MDChecked 2026-09-29
Official clinical specialist profile; public service record, not a personal diagnosis or outcome
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
RUSH: Urology ServicesChecked 2026-09-29
Official adult clinical urology service; public service record, not a personal diagnosis or outcome
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Endocrine Society: Testosterone Therapy for Hypogonadism Guideline ResourcesChecked 2026-09-29
2018 professional clinical guideline summary, inspected September 29, 2026; dated clinical reference, not a product-specific implemented label
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
- NYU Langone testosterone assessment: reading the clinical remit
- NewYork-Presbyterian testosterone assessment: the multispecialty setting
- Yale Medicine testosterone assessment: what a clinician profile proves
- RUSH testosterone assessment: the limits of a second-opinion page
- Hartford HealthCare testosterone assessment: following the cause
- Henry Ford testosterone assessment: beyond the treatment list
- Corewell Health testosterone assessment: an endocrine care record
- Geisinger testosterone assessment: the boundaries of a named practice
- UCSF testosterone assessment: measurements and meaningful improvement
Endocrine Society: Statement on Testosterone Replacement Therapy, July 16, 2026Checked 2026-09-29
Current professional policy/clinical statement; dated clinical reference, not a product-specific implemented label
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
- NYU Langone testosterone assessment: reading the clinical remit
- NewYork-Presbyterian testosterone assessment: the multispecialty setting
- Yale Medicine testosterone assessment: what a clinician profile proves
- RUSH testosterone assessment: the limits of a second-opinion page
- Hartford HealthCare testosterone assessment: following the cause
- Henry Ford testosterone assessment: beyond the treatment list
- Corewell Health testosterone assessment: an endocrine care record
- Geisinger testosterone assessment: the boundaries of a named practice
FDA: Testosterone InformationChecked 2026-09-29
Current regulator overview with June 2026 requested-label-change discussion; dated clinical reference, not a product-specific implemented label
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
- NYU Langone testosterone assessment: reading the clinical remit
- NewYork-Presbyterian testosterone assessment: the multispecialty setting
- Yale Medicine testosterone assessment: what a clinician profile proves
- RUSH testosterone assessment: the limits of a second-opinion page
- Hartford HealthCare testosterone assessment: following the cause
- Henry Ford testosterone assessment: beyond the treatment list
- Corewell Health testosterone assessment: an endocrine care record
- Geisinger testosterone assessment: the boundaries of a named practice
- UCSF testosterone assessment: measurements and meaningful improvement
UPMC: actual low-testosterone/hypogonadism serviceChecked 2026-09-29
Institutional clinical-service evidence; plain attribution, not referral or clinical outcome evidence
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
UC San Diego Health: actual low-testosterone/hypogonadism serviceChecked 2026-09-29
Institutional clinical-service evidence; plain attribution, not referral or clinical outcome evidence
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
UCI Health: actual low-testosterone/hypogonadism serviceChecked 2026-09-29
Institutional clinical-service evidence; plain attribution, not referral or clinical outcome evidence
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
UC Davis Health: actual low-testosterone/hypogonadism serviceChecked 2026-09-29
Institutional clinical-service evidence; plain attribution, not referral or clinical outcome evidence
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Keck Medicine of USC: actual low-testosterone/hypogonadism serviceChecked 2026-09-29
Institutional clinical-service evidence; plain attribution, not referral or clinical outcome evidence
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
OHSU: actual low-testosterone/hypogonadism serviceChecked 2026-09-29
Institutional clinical-service evidence; plain attribution, not referral or clinical outcome evidence
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
UW Medicine: actual low-testosterone/hypogonadism serviceChecked 2026-09-29
Institutional clinical-service evidence; plain attribution, not referral or clinical outcome evidence
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Vanderbilt Health: actual low-testosterone/hypogonadism serviceChecked 2026-09-29
Institutional clinical-service evidence; plain attribution, not referral or clinical outcome evidence
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Emory Healthcare: actual low-testosterone/hypogonadism serviceChecked 2026-09-29
Institutional clinical-service evidence; plain attribution, not referral or clinical outcome evidence
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
UC San Diego Health: Men’s Reproductive & Sexual HealthChecked 2026-09-29
Institutional clinical-service evidence; plain attribution, not referral or clinical outcome evidence
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
UCI Health: Men’s Health ServicesChecked 2026-09-29
Institutional clinical-service evidence; plain attribution, not referral or clinical outcome evidence
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
UC Davis Health: Urologic Surgery specialtiesChecked 2026-09-29
Institutional clinical-service evidence; plain attribution, not referral or clinical outcome evidence
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Vanderbilt Health: Endocrinology, Diabetes and MetabolismChecked 2026-09-29
Institutional clinical-service evidence; plain attribution, not referral or clinical outcome evidence
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Emory Healthcare: Low Testosterone TreatmentsChecked 2026-09-29
Institutional clinical-service evidence; plain attribution, not referral or clinical outcome evidence
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
FDA: February 28, 2025 class-wide labeling announcementChecked 2026-09-29
Independent professional/regulatory context; exact date and scope retained
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
Endocrine Society: 2018 hypogonadism guideline resourcesChecked 2026-09-29
Independent professional/regulatory context; exact date and scope retained
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
- UPMC testosterone assessment review: what a listed clinical service establishes
- UC San Diego Health testosterone assessment review: read the evaluation before the options
- UCI Health testosterone assessment review: separate related conditions from one diagnosis
- UC Davis Health testosterone assessment review: make the cause visible in the record
- Keck Medicine testosterone assessment review: distinguish fertility and sexual-health goals
- OHSU testosterone assessment review: a cause-focused service description
- UW Medicine testosterone assessment review: records and questions
- Vanderbilt Health testosterone assessment review: read a condition directory within its limits
- Emory Healthcare testosterone assessment review: connect the diagnosis with its explanation
Endocrine Society: July 16, 2026 statement on testosterone replacementChecked 2026-09-29
Independent professional/regulatory context; exact date and scope retained
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
- UPMC testosterone assessment review: what a listed clinical service establishes
- UC San Diego Health testosterone assessment review: read the evaluation before the options
- UCI Health testosterone assessment review: separate related conditions from one diagnosis
- UC Davis Health testosterone assessment review: make the cause visible in the record
- Keck Medicine testosterone assessment review: distinguish fertility and sexual-health goals
- OHSU testosterone assessment review: a cause-focused service description
- UW Medicine testosterone assessment review: records and questions
- Vanderbilt Health testosterone assessment review: read a condition directory within its limits
- Emory Healthcare testosterone assessment review: connect the diagnosis with its explanation
FDA: current Testosterone InformationChecked 2026-09-29
Independent professional/regulatory context; exact date and scope retained
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
- UPMC testosterone assessment review: what a listed clinical service establishes
- UC San Diego Health testosterone assessment review: read the evaluation before the options
- UCI Health testosterone assessment review: separate related conditions from one diagnosis
- UC Davis Health testosterone assessment review: make the cause visible in the record
- Keck Medicine testosterone assessment review: distinguish fertility and sexual-health goals
- OHSU testosterone assessment review: a cause-focused service description
- UW Medicine testosterone assessment review: records and questions
- Vanderbilt Health testosterone assessment review: read a condition directory within its limits
- Emory Healthcare testosterone assessment review: connect the diagnosis with its explanation
Duke Health — Pituitary DisordersChecked 2026-09-29
Official clinical program, internally reviewed January 24, 2025. Explicit central hypogonadism and integrated endocrine care; not evidence that an individual has pituitary disease or needs every listed investigation.
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Duke Health — Adrienne Barnosky, DOChecked 2026-09-29
Official adult endocrinologist profile explicitly including hypogonadism. A documented clinical scope, without ratings, outcome claims or verified personal access.
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Duke Health — Duke Pituitary Program Expands Expertise With New Physician LeadershipChecked 2026-09-29
Official clinical program discussion of male hypogonadism, underlying causes, second opinions and referring-clinician coordination. Telemedicine is qualified by appropriateness; no universal remote access or confirmed treatment.
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Cleveland Clinic — Get Low Testosterone TreatmentChecked 2026-09-29
Official assessment and follow-up service describing symptom history, medicine and health history, examination and possible tests. Northeast Ohio and Florida locations. Missing extracted lists are not reconstructed or treated as a complete formulary.
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Mayo Clinic — Male hypogonadism: Doctors and departmentsChecked 2026-09-29
Official condition-specific care directory, dated September 20, 2025. Endocrinology and pituitary-gonad-adrenal specialty group plus a displayed Rochester clinician. Does not establish identical access at every campus.
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Mayo Clinic — Men’s Health overviewChecked 2026-09-29
Official Rochester, Minnesota men’s health program, dated October 31, 2024. Clinical breadth and research activity are not individual outcomes or comparative performance. The separate condition directory confirms specific hypogonadism care.
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Johns Hopkins Medicine — Amin Herati, MDChecked 2026-09-29
Official urologist profile explicitly treating low testosterone and directing Male Infertility and Men’s Health. Background practice locations and detailed Lutherville location remain distinct. Availability badges, ratings and insurance lists are not personal access confirmation.
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Mount Sinai — Male Hormone DisordersChecked 2026-09-29
Official endocrinology service diagnosing and treating hypogonadism, investigating causes and collaborating on infertility. Timing instructions, personal diagnostic rules and claimed research benefits are not reproduced as advice.
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Northwestern Medicine — HypogonadismChecked 2026-09-29
Official condition-and-care record explicitly describing a reproductive urologist’s history, examination and cause assessment. The concise page does not establish a named formulation, supplied medicine or detailed follow-up schedule.
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
UCLA Health — The Men’s Clinic at UCLAChecked 2026-09-29
Official low-testosterone clinical service within a wider reproductive and men’s health program. Santa Monica and video descriptions do not establish unrestricted access. Listed forms and collaboration do not confirm a selected prescription or completed consultation.
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
UCLA Health — Low TestosteroneChecked 2026-09-29
Official clinic condition page used for blood-assessment context. Broad response timelines, minimal-adverse-effect assurances, administration instructions and fixed monitoring intervals are not adopted; independent current guidance qualifies the assessment discussion.
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Stanford Health Care — Hypogonadism diagnosisChecked 2026-09-29
Official diagnosis outline covering symptoms, examination and hormone testing, linked to actual endocrine, urology and male reproductive services. No individual testing algorithm, universal clinic access or specified product inferred.
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
University of Utah Health — HypogonadismChecked 2026-09-29
Official clinical assessment, follow-up and fertility discussion. Questionnaire reference is not a diagnosis or eligibility rule. Older general reassurance and references are qualified by current independent guidance; no technique, dosage, response guarantee or acquisition instructions reproduced.
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Endocrine Society — Testosterone Therapy for Hypogonadism Guideline ResourcesChecked 2026-09-29
Professional guideline resource dated March 19, 2018; accessible recommendations summary, not a claim to have retrieved the complete journal article. Diagnosis, cause evaluation, fertility cautions and clinical monitoring principles; no personal thresholds, dose or testing calendar.
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
- Duke Health testosterone assessment review: causes and referrals
- Cleveland Clinic testosterone assessment review: what the first conversation needs to establish
- Mayo Clinic testosterone assessment review: read the condition directory and the clinical role together
- Johns Hopkins Medicine testosterone assessment review: connect endocrine questions with reproductive history
- Mount Sinai testosterone assessment review: look for the condition behind the hormone finding
- Northwestern Medicine testosterone assessment review: what a concise care record does establish
- UCLA Health testosterone assessment review: scope and handoffs
- Stanford Health Care testosterone assessment review: three kinds of evidence, one clinical explanation
- University of Utah Health testosterone assessment review: keep the questionnaire separate from the diagnosis
Endocrine Society — Statement on Testosterone Replacement Therapy, July 16, 2026Checked 2026-09-29
Current professional statement on accurate diagnosis, reversible contributors, limits of asymptomatic screening, testing quality and unresolved long-term safety. No numerical cutoff, regimen or personal treatment decision reproduced.
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
- Duke Health testosterone assessment review: causes and referrals
- Cleveland Clinic testosterone assessment review: what the first conversation needs to establish
- Mayo Clinic testosterone assessment review: read the condition directory and the clinical role together
- Johns Hopkins Medicine testosterone assessment review: connect endocrine questions with reproductive history
- Mount Sinai testosterone assessment review: look for the condition behind the hormone finding
- Northwestern Medicine testosterone assessment review: what a concise care record does establish
- UCLA Health testosterone assessment review: scope and handoffs
- Stanford Health Care testosterone assessment review: three kinds of evidence, one clinical explanation
- University of Utah Health testosterone assessment review: keep the questionnaire separate from the diagnosis
U.S. Food and Drug Administration — Testosterone InformationChecked 2026-09-29
Official regulatory overview reporting June 2026 requested labeling updates and AndroGel-specific TRAVERSE context. A request does not prove implementation in each product document; findings are not reassigned to unidentified injectable products or presented as blanket safety clearance.
Source checked 2026-09-29. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
Enhanced: testosterone injections and get-started offer (checked October 13, 2026)Checked 2026-10-13
Provider public service document
Source checked 2026-10-13. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
FDA: risks of compounded medicines (checked October 13, 2026)Checked 2026-10-13
Primary clinical or regulatory guidance
Source checked 2026-10-13. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
Enhanced: terms of service (checked October 13, 2026)Checked 2026-10-13
Provider public service document
Source checked 2026-10-13. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Lowcountry Male: clinic services and cypionate listing (checked October 13, 2026)Checked 2026-10-13
Provider public service document
Source checked 2026-10-13. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Lowcountry Male: plans, consultation and insurance conditions (checked October 13, 2026)Checked 2026-10-13
Provider public service document
Source checked 2026-10-13. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Enhanced: TRT supply offers and compounded cypionate (checked October 13, 2026)Checked 2026-10-13
Provider public service document
Source checked 2026-10-13. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
FDA: class-wide testosterone labeling changes (checked October 13, 2026)Checked 2026-10-13
Primary clinical or regulatory guidance
Source checked 2026-10-13. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
Endocrine Society: testosterone therapy guideline (checked October 13, 2026)Checked 2026-10-13
Primary clinical or regulatory guidance
Source checked 2026-10-13. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
Pfizer label: October 2025Checked 2026-11-08
Product document
Source checked 2026-11-08. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
DailyMed: September 2025 textChecked 2026-11-08
Product document
Source checked 2026-11-08. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
Endocrine Society: July 2026 statementChecked 2026-11-08
Professional commentary
Source checked 2026-11-08. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
Endocrine Society: 2018 resourceChecked 2026-11-08
Guideline resource
Source checked 2026-11-08. This is an access date, not necessarily the document’s revision date.
Open the original document →Articles using this source
UCLA: clinic overviewChecked 2026-11-08
Institutional description
Source checked 2026-11-08. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Duke: pituitary serviceChecked 2026-11-08
Institutional description
Source checked 2026-11-08. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Duke: January 2025 program accountChecked 2026-11-08
Historical program article
Source checked 2026-11-08. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Defy: cost discussionChecked 2026-11-08
Provider account
Source checked 2026-11-08. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.
Articles using this source
Defy: April 2026 termsChecked 2026-11-08
Provider terms
Source checked 2026-11-08. This is an access date, not necessarily the document’s revision date.
Provider document retained as a dated source record. This educational publication does not link to medicine shopping pages.